ArticleNan fang yi ke da xue xue bao = Journal of Southern Medical University2026
[
Article in Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo investigate the therapeutic mechanism of
methodsTwenty male SD rat models of RA with WCDA were randomized into two equal groups for daily gavage with saline (model group) or SJF for 14 consecutive days, with 10 normal rats serving as the normal control group. The changes in body weight, general condition, and plantar swelling of the rats were monitored. Serum levels of interleukin-10 (IL-10), IL-17, IL-21, and tumor necrosis factor alpha (TNF-α) were measured using ELISA, and Th17 and Treg cell percentages in peripheral blood and splenic T cell subsets were analyzed by flow cytometry. RT-qPCR and Western blotting were used to detect the mRNA and protein expression levels of retinoic acid-related orphan receptor γt (RORγt) and forkhead box P3 (Foxp3) in the ankle joint synovial tissue.
resultsIn the rats models of RA with WCDA, SJF gavage significantly improved the general condition, reduced foot swelling, downregulated serum levels of IL-17, IL-21, and TNF-α, upregulated IL-10 level, and obviously increased Treg cell percentage while decreasing Th17 cell percentage. SJF treatment also significantly suppressed the expressions of RORγt mRNA and protein, promoted Foxp3 mRNA and protein expressions, and alleviated synovial inflammatory cell infiltration in the rat models.
conclusionsSJF regulates inflammatory cytokine levels, Th17/Treg ratio, and RORγt/Foxp3 expressions in RA rat model with WCDA, suggesting that its therapeutic efficacy for RA is mediated primarily by ameliorating joint inflammation and pathologies via modulating the Th17/Treg balance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.